Does a drug-coated balloon-only strategy provide safe and efficient outcomes in patients with stable CAD and ACS undergoing PCI for de novo lesions?
A DCB-only strategy for PCI in de novo lesions is safe and efficient across both stable CAD and ACS, offering a potentially useful approach for patients at high bleeding risk.
PCI using DCB-only strategy with the possibility for provisional stenting is a safe and efficient in de novo coronary artery lesions in both stable CAD and ACS. This strategy may be useful especially in patients with high bleeding risk.
Uskela et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: